Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Public ClinicalTrials.gov record NCT04057040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of the Hepcidin Mimetic PTG-300 in Patients With Phlebotomy-Requiring Polycythemia Vera
Study identification
- NCT ID
- NCT04057040
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Protagonist Therapeutics, Inc.
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- PTG-300 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2019
- Primary completion
- Feb 13, 2023
- Completion
- Jun 16, 2024
- Last update posted
- Aug 6, 2025
2019 – 2024
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Marin Cancer Care | Greenbrae | California | 94904 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| University of Kansas | Westwood | Kansas | 66205 | — |
| Pontchartrain Cancer Care | Covington | Louisiana | 70433 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Center | Detroit | Michigan | 48201 | — |
| Mount Sinai | New York | New York | 10029 | — |
| New York Presbyterian Hospital - Weill Cornell Medical Center | New York | New York | 10065 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44106 | — |
| Mary Crowley Cancer Research Center | Dallas | Texas | 75230 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04057040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04057040 live on ClinicalTrials.gov.